Under the guidance of Programme Management Officer or his designee, the Individual Contractor will: • Assess existing literature, collect, compile, and analyze fully anonymized data on accidental or deliberate adulteration, substitution and/or falsification of pharmaceutical grade solvents (namely propylene glycol, glycerol and sorbitol) with diethylene glycol and/or ethylene glycol. • Collate typologies relating to criminal networks and actors involved in the manufacturing of both industrial and pharmaceutical-grade solvents (namely propylene glycol, glycerol, and sorbitol). • Create a risk assessment tool and associated sample activities to mitigate the risk of accidental adulteration, substitution and/or falsification of pharmaceutical-grade products with industrial grade substances. • Identify to the greatest extent possible the frequency of conduct of gap analysis of the pharmaceutical manufacturers” quality management systems to identify, report and refer instances of “near misses” related to the risk of potential use of contaminated solvents, determine if these events are recorded, and identify whether these events are reported to the National Regulatory Authorities (NRA) and consideration of parallel criminal investigations. • Collate typologies relating to the role and identities of facilitators involved in the supply chain of pharmaceutical-grade solvents, and-subject to the prior authorization and cooperation of the relevant Member State(s) in question- assess the oversight and regulatory mechanisms governing the activities of such facilitators. • Identify the types of offences in the deliberate adulteration, substitution and/or falsification of pharmaceutical-grade solvents. • Create a core disruption toolkit to include public, private and civil sector disruption options on how to: o mitigate the risks associated with propylene glycol and glycerol, considering the findings of the analysis. o improve oversight, control, and prevention of deliberate or accidental adulteration, substitution and/or falsification of propylene glycol and glycerol within the supply chain. o other legal interventions, disruption methods, and intelligence products that may be deployed to counter intentional adulteration/falsification of pharmaceutical grade solvents. • Facilitate and lead an expert working group meeting on “Strategic and Tactical Interventions to Address Medical Products Related Crimes” to gather insights from a multi-disciplinary group of experienced practitioners with diverse backgrounds and knowledge to inform and develop strategies on more effectively combatting medical products related crimes.

Home-based

01-15 August 2025

Under the guidance of Programme Management Officer or his designee, the Individual Contractor will: • Assess existing literature, collect, compile, and analyze fully anonymized data on accidental or deliberate adulteration, substitution and/or falsification of pharmaceutical grade solvents (namely propylene glycol, glycerol and sorbitol) with diethylene glycol and/or ethylene glycol. • Collate typologies relating to criminal networks and actors involved in the manufacturing of both industrial and pharmaceutical-grade solvents (namely propylene glycol, glycerol, and sorbitol). • Create a risk assessment tool and associated sample activities to mitigate the risk of accidental adulteration, substitution and/or falsification of pharmaceutical-grade products with industrial grade substances. • Identify to the greatest extent possible the frequency of conduct of gap analysis of the pharmaceutical manufacturers” quality management systems to identify, report and refer instances of “near misses” related to the risk of potential use of contaminated solvents, determine if these events are recorded, and identify whether these events are reported to the National Regulatory Authorities (NRA) and consideration of parallel criminal investigations. • Collate typologies relating to the role and identities of facilitators involved in the supply chain of pharmaceutical-grade solvents, and-subject to the prior authorization and cooperation of the relevant Member State(s) in question- assess the oversight and regulatory mechanisms governing the activities of such facilitators. • Identify the types of offences in the deliberate adulteration, substitution and/or falsification of pharmaceutical-grade solvents. • Create a core disruption toolkit to include public, private and civil sector disruption options on how to: o mitigate the risks associated with propylene glycol and glycerol, considering the findings of the analysis. o improve oversight, control, and prevention of deliberate or accidental adulteration, substitution and/or falsification of propylene glycol and glycerol within the supply chain. o other legal interventions, disruption methods, and intelligence products that may be deployed to counter intentional adulteration/falsification of pharmaceutical grade solvents. • Facilitate and lead an expert working group meeting on “Strategic and Tactical Interventions to Address Medical Products Related Crimes” to gather insights from a multi-disciplinary group of experienced practitioners with diverse backgrounds and knowledge to inform and develop strategies on more effectively combatting medical products related crimes.

A high school diploma or equivalent is required. At least ten years of professional experience in market surveillance and vigilance is required. Experience in government service, and strong knowledge about the WHO rapid alert system is required. Technical knowledge in WHO and other internationally recognized quality assurance standards and health product regulations is required. Experience in writing policy, strategic and technical reports is desirable. Working experience with UN and WHO administrative systems is desirable. Working experience in or with national / regional medical products’ regulatory authorities is desirable.

English and French are the working languages of the United Nations Secretariat. For this position, fluency in English is required. Knowledge of another United Nations official language is an advantage.

Not available.

THE UNITED NATIONS DOES NOT CHARGE A FEE AT ANY STAGE OF THE RECRUITMENT PROCESS (APPLICATION, INTERVIEW MEETING, PROCESSING, OR TRAINING). THE UNITED NATIONS DOES NOT CONCERN ITSELF WITH INFORMATION ON APPLICANTS’ BANK ACCOUNTS.